- Home
- Products
- Customized FluoroAb™
- CA9
- Girentuximab-Cy3
Girentuximab-Cy3 (CAT#: ADC-FL-284)
- TARGET
- ANTIBODY
- DYE
- Name
- CA9
- Alternative Names
- CA9; carbonic anhydrase IX; carbonic anhydrase 9; CAIX; carbonic dehydratase; MN; RCC associated protein G250; pMW1; CA-IX; P54/58N; membrane antigen MN; carbonate dehydratase IX; RCC-associated antigen G250; RCC-associated protein G250; renal cell carcinoma-associated antigen G250;
- Overview
- Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12.
- Overview
- Chimeric Anti-CA9 IgG1-Fab’ fragment , Girentuximab
- Generic name
- Girentuximab
- Species Reactivity
- Human
- Name
- Cy3
- Color
- Orange
- Excitation⁄Emission (nm)
- 554/568
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-284. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-741 | Anti-CA9 (Girentuximab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-745 | Anti-CA9 (Girentuximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-742 | Anti-CA9 (Girentuximab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-740 | Anti-CA9 (Girentuximab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-744 | Anti-CA9 (Girentuximab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Lintuzumab-Cy3 (CAT#: ADC-FL-500)
- Anti-TNF MAb (Clone 17)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13822)
- Anti-PVRL4 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16173)
- Anti-IAV HA MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16184)
- Anti-CD3E MAb (Clone 4)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11538)
- Anti-RSV MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4644)
- Anti-ITGAV MAb (Clone 4)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13104)
- Anti-LAMP1 MAb (Clone 6)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3362)
- Anti-HGF MAb (Clone 10)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13576)
- Anti-FOLR1 MAb (Clone 8)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5615)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
